共 95 条
[1]
Flanigan RC(2001)Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 345 1655-1659
[2]
Salmon SE(2001)Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial Lancet 108 1279-1283
[3]
Blumenstein BA(2004)Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis J Urol 247 2543-2546
[4]
Mickisch GHJ(2011)The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy J Urol 35 97-105
[5]
Garin A(2014)Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium Eur Urol 250 607-610
[6]
van Poppel H(2015)Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features Urol Oncol 84 7251-7255
[7]
Flanigan RC(2016)Cytoreductive nephrectomy in metastatic renal cell carcinoma treated with targeted therapies: a systematic review with a meta-analysis Clin Genitourin Cancer undefined undefined-undefined
[8]
Mickisch G(2011)The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy J Urol undefined undefined-undefined
[9]
Sylvester R(2010)Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? Cancer undefined undefined-undefined
[10]
Choueiri TK(2011)Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy Ann Oncol Off J Eur Soc Med Oncol ESMO undefined undefined-undefined